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Background: Gastric cancer is the second most common cause of death from cancer in the world. Epidemiological
findings on alcohol use in relation to gastric cancer remain controversial. The aim of this study was to examine the
effect of alcohol consumption on the risk of gastric cancer.
Methods: The association between alcohol intake and the risk of gastric cancer was examined in a
population-based cohort of 7,150 men in Kaunas, Lithuania, who were enrolled during 1972–1974 or 1976–1980.
After up to 30 years of follow-up, 185 gastric cancer cases were identified. Multivariate Cox proportional hazards
models were used to estimate hazard ratios (HR) and corresponding 95% confidence intervals (95% CI). The
attained age was used as a time-scale.
Results: After adjustment for smoking, education level and body mass index, the HR of gastric cancer was 2.00
(95% CI: 1.04–3.82) for the highest alcohol consumption frequency (2–7 times per week) compared with
occasional drinking (a few times per year) and 1.90 (95% CI: 1.13–3.18) for ≥100.0 g ethanol/week versus 0.1–9.9
g ethanol/week. A stronger effect of alcohol consumption on gastric cancer risk was observed during the
second half of the study (1993–2008). In the analysis of gastric cancer risk by alcoholic beverage type, all
beverages were included simultaneously in the model. The multivariate HR for men who consumed ≥0.5 litre
of wine per occasion (compared with those who consumed <0.5 litre) was 2.95 (95% CI: 1.30–6.68). Higher
consumption of beer or vodka was not statistically significantly associated with gastric cancer risk. After
adjustment for smoking, education level, body mass index and ethanol, we found no excess risk of gastric
cancer in association with total acetaldehyde intake.
Conclusions: This study supports a link between alcohol consumption (primarily from ethanol) and the
development of gastric cancer in the Lithuanian population. Although an association with heavy wine
consumption was observed, the effect of exposure to acetaldehyde on the development of gastric cancer in
this cohort was not confirmed. Further research is needed to provide a more detailed evaluation of alcohol
drinking and gastric cancer risk.
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Despite the declining incidence and mortality rates, gas-
tric cancer represents the fourth most common incident
cancer and the second most common cause of death
from cancer in the world [1]. There were 988,602 new
cases and 737,419 deaths in 2010 worldwide [1]. The
considerable geographic variation in incidence and mor-
tality rates indicates that environmental and lifestyle fac-
tors play an important role in the etiology of gastric
cancer. Infection with Helicobacter pylori and smoking
are established risk factors; however, alcohol consump-
tion, diet and genetic factors may also play a role in gas-
tric carcinogenesis [2].
Epidemiological studies have reported controversial
findings on the association between alcohol consump-
tion and the risk of gastric cancer. In 2007, the Inter-
national Agency for Research on Cancer classified
alcohol consumption as a group 1 human carcinogen,
related to cancers of the oral cavity, pharynx, larynx,
oesophagus, liver, colorectum, and female breast [3,4]. It
was concluded that epidemiological evidence concerning
the association between alcohol drinking and gastric
cancer is inconclusive. Several published case–control
and cohort studies on alcohol and gastric cancer have
found no significant association [5-13]. In contrast, other
studies reported an increased risk of gastric cancer asso-
ciated with alcohol consumption [14-19]. An extensive
meta-analysis of data published until June 2010 con-
cluded that moderate alcohol consumption is probably
not related to gastric cancer, but there was a positive as-
sociation with heavy alcohol drinking [20]. Risk was
higher for gastric noncardia than for gastric cardia
adenocarcinoma. In addition, significant heterogeneity in
relative risks for heavy alcohol drinking by geographic
area was observed, with higher risk among non-Asian
studies. However, there are still issues that need to be
resolved. The beverage-specific effects were not investi-
gated in the meta-analysis, therefore, it remains unclear
whether there is relation between type of alcoholic bev-
erage and gastric cancer. There is a major knowledge
gap regarding information about the potential impact of
acetaldehyde on cancer risk [21]. Furthermore, little in-
formation is available on the long-term effects of alcohol
consumption on gastric cancer risk. Whereas there is a
high number of epidemiological studies on alcohol
drinking in relation to gastric cancer, prospective epi-
demiological studies in populations with a high risk are
lacking.
In Lithuania, gastric cancer incidence and mortality
rates among men and women are higher than in most
European countries, with incidence rates of 33.8 per
100,000 in men and 14.4 for women in Lithuania, and
16.7 for men and 7.8 for women in 27 countries of the
European Union (EU-27) [22]. Similarly, mortality ratesare higher in Lithuania (29.9 in men and 10.2 in women)
than in EU-27 (12.0 in men and 5.6 in women). Clarify-
ing the role of alcohol consumption in the etiology of
gastric cancer is important, because the consumption of
alcohol is widespread. A high overall amount of alcohol
consumption and a high level of binge drinking as com-
pared to other European countries have been reported
in Lithuania: 39% of men drank ≥60 g of pure alcohol
on a single occasion at least once per month in 2010
[23,24]. The aim of our study was to evaluate the associ-
ation between the alcohol consumption (frequency, etha-
nol intake in grams per week and acetaldehyde intake in
milligrams per week) and the risk of gastric cancer in a
30 year population-based cohort study of 7,150 men in
Lithuania. We also investigated the impact of the type of
alcoholic beverage. In this article we also report findings
from a second half of the follow-up period (1993–2008).
Methods
Study population
Two cohorts - Kaunas Rotterdam Intervention Study
(KRIS) and Multifactorial Ischemic Heart Disease Pre-
vention Study (MIHDPS) - are included. KRIS is a
WHO-coordinated prospective cohort study of a ran-
dom sample of 2,447 men aged 45–59, living in the city
of Kaunas (Lithuania), who took part in a cardiovascular
screening programme in 1972–1974 (69% of eligible par-
ticipants). The MIHDPS was carried out in 1977–1980
among 5,933 Kaunas men, aged 40–59, representing
70% of eligible participants. These are prospective
population-based studies designed to investigate risk fac-
tors for cardiovascular diseases and other health-related
outcomes among urban population of middle-aged men
from Kaunas. The city of Kaunas is located in central
Lithuania, which has about 336,000 inhabitants, while
the total population of the Lithuania is 3.2 million.
Both studies were based on voluntary, informed par-
ticipation. Participants gave no written informed consent
prior to the baseline examination as this was not
required in the former Soviet Union. The current study,
including the use of data from the 1970s without written
informed patients’ consent, was approved by the Re-
gional Biomedical Research Ethical Committee in 2011
(No. 158200-02-280-65).
Exposure assessment
All participants underwent physical examination; infor-
mation on alcohol consumption and potential confoun-
ders, including demographic factors and smoking, was
obtained via interview. The usual frequency of intake
and usual dose for each type of drink (beer, wine, vodka)
were recorded using a structured questionnaire [25-27].
Participants were asked how frequently they consumed
alcohol, the answer choices were: several times per year,
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or daily. Furthermore, they were asked how much of
each type they drank per occasion. The response options
were, for beer: no beer, < 1 litre, ≥1 litre; for wine: no
wine, <0.5 litre, ≥0.5 to <1 litre, ≥1 litre; for vodka: no
vodka, <200 g, ≥200 g (MIHDPS study); or: no vodka,
<100 g, ≥100 g (KRIS study).
Cancer ascertainment and follow-up
Study participants were followed from 1 January 1978 to
31 December 2008. We identified cases of gastric cancer
from the Lithuanian Cancer Registry, which has
population-based information available since 1978. In
addition, deaths from gastric cancer were identified in
the National and Regional Archives on Causes of Death.
For the present study, the gastric cancer codes were
151.0 to 151.9 of ICD-9 or C16.0 to C16.9 of ICD-10
(International Statistical Classification of Diseases, 9th
or 10th Revision respectively). The ascertainment of
dates of death and dates of emigration was accomplished
by linkage to the Lithuanian Residents’ Register Service.
A description of the follow-up is presented in Figure 1.
In all, 8,380 cohort members were available for analysis.
We excluded 1,230 men because of unknown vital status
(4.6%), death before start of follow-up (2.7%), cancer
other than nonmelanoma skin cancer before start of
follow-up (0.9%), duplicates (5.6%) or incomplete alcohol
consumption information (0.8%). Complete data on al-
cohol consumption was available for 7,150 men.Linkage procedures with 
National Cancer Registry and 















Cancer before start 
of follow-up, n=79
Figure 1 Flow diagram of data management and selection of
subjects for the study.Statistical analyses
The association between alcohol consumption and gas-
tric cancer incidence was evaluated using multivariate
Cox proportional hazard models. Attained age in
months was used as time-scale. Time at entry was the
age at the beginning of follow-up, exit time was the age
when participants were diagnosed with cancer, died,
were lost to follow-up, or were censored at the end of
the follow-up period, whichever came first. Study sub-
jects were followed from 1 January 1978 to 31 December
2008. For the MIHDPS study, to reduce the possibility
of reverse causation, we excluded the first 3 years of fol-
low-up. The Cox models were stratified by study, using
‘study’ as a stratification variable, to control for study-
specific effects.
Participants were grouped into four groups on the
basis of answers to the question on frequency of alcohol
consumption. To improve precision groups were merged
into: non-drinkers (i.e. never or former drinkers), a few
times per year, 1–4 times per month (i.e. once per
month to once per week), 2–7 times per week (i.e. a few
times per week to daily). The measures of average
weekly intake of ethanol (in grams) from all alcoholic
beverages or from specific beverages were calculated on
the basis of reported amounts and frequencies of drink-
ing. Alcohol intake categories were converted into the
number of alcohol units, and then into grams of ethanol
per week, by calculating the dose as the mid-point of
each category. For upper open-ended categories, the
lower limit was multiplied by 1.2 [20]. A unit was
defined as 10 g of ethanol [28]. Individuals were classi-
fied into five groups according to their amount of etha-
nol consumed from all beverages or from specific
beverages: non-drinkers, 0.1–9.9 g/week, 10.0–24.9 g/
week, 25.0–99.9 g/week and ≥100 g/week. The cut-
points were selected on the basis of cohort distribution
and aiming to retain extreme categories and sufficient
number of cases in sub-groups. For analyses by type of
alcoholic beverage, we merged some categories for
higher consumption due to limited number of gastric
cancer cases. In addition, alcohol intake was converted
into milligrams of acetaldehyde per week using acetalde-
hyde content for each type of alcoholic beverage (beer,
wine and vodka) according to Lachenmeier et al. [21]:
beer - 18 g/hl of pure alcohol, wine – 28 g/hl of pure al-
cohol, vodka – 0.7 g/hl of pure alcohol. Weekly acetalde-
hyde consumption was calculated by combining the
frequency of drinking and amount of total acetaldehyde
consumption per one occasion. Individuals who con-
sumed alcohol were categorized into approximate quin-
tiles based on the acetaldehyde intake distribution
observed in the cohort. The cut-off points used were
0.10, 0.21, 0.86 and 4.11 mg/week. We assumed that oc-
casional drinkers or participants with very light alcohol
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cer because some non-drinkers may have quit due to
health problems possibly related to gastric cancer risk.
Our assumption is based on earlier results from the
meta-analysis, where j-shaped dose–response relation-
ship was found and on evidence from EPIC cohort ana-
lysis, where non-consumers and former drinkers were at
elevated risk for gastric cancer [19,20]. Thus, occasional
drinkers (who drank alcohol a few times per year) or
participants with very light alcohol consumption (0.1–
9.9 g ethanol/week or 0.01–0.10 mg acetaldehyde/week)
were used as a reference. Risk estimates for beer, wine
and vodka used lighter drinkers of each alcohol type as a
reference.
We computed Cox proportional hazard models to ob-
tain Hazard Ratios and 95% Confidence Intervals for al-
cohol consumption variables, adjusted for potential
confounders such as cigarette smoking (never, former,
≤10 cig/day, 11–19 cig/day, ≥20 cig/day), education
level (primary, unfinished secondary, secondary and
higher), body mass index (BMI) (as a continuous vari-
able). In the analysis of beer, wine and vodka consump-
tion, all beverages were included simultaneously in the
model. Because it has been suggested, that the acetalde-
hyde should be considered as confounding factor in epi-
demiological studies on alcohol consumption [21], the
analysis for ethanol and acetaldehyde intake was
repeated with mutual adjustment for these factors. In
addition, adjustment for cholesterol and physical activity
did not change materially the results, so these variables
were not included in the final statistical model. For cat-
egorical covariates for which information was missing,
we assigned a separate category, while missing data for
continuous variable was replaced by the sample mean.
Less than 2.5% of the cohort lacked data for each cov-
ariate. After excluding non-drinkers, we tested for linear
trend by fitting ordinal alcohol consumption variables
as continuous. Additionally, standard deviation (SD)
scores for the ethanol intake (g/week) and acetaldehyde
intake (mg/week) variables were calculated and the
multivariable-adjusted HRs associated with an increase
in 1 SD were estimated. We also calculated the corre-
sponding HR estimates for gastric cancer for the second
half of the follow-up period (1993–2008) to better as-
sess the long-term effect of alcohol consumption. Can-
cer incidence per 10,000 person-years of follow-up was
calculated by dividing the number of cancer cases by
the total number of person-years and multiplying by
10,000. To determine the public health impact of heavy
drinking, we calculated the population attributable frac-
tion (AF) of heavy alcohol consumption (≥100.0 g/
week) on gastric cancer risk using the formula: AF = [P
(RR – 1)]/RR, where P is the proportion of cases
exposed to a given exposure category of alcohol and RRis the adjusted relative risk for this category [29]. The
AF is the estimate of the fraction of cases that would
not have occurred if exposure had not occurred [29].
We tested the proportional hazards assumption using
the Schoenfeld test. There was no evidence that the
proportional hazards assumption was violated for any of
the exposure and adjustment variables. We assessed for
the interactions between alcohol variables and covari-
ates by using likelihood ratio test (none of the interac-
tions were significant). Analyses were performed using
STATA 10. All tests were two-tailed, and statistical sig-
nificance was assessed at the 5% level.
Results
Characteristics of the study population according to
reported alcohol consumption frequency are shown in
Table 1. Men within the group of the highest frequency
of alcohol consumption were more likely to smoke and
to smoke heavily, and less likely to have a higher educa-
tion. About 8% of participants were non-drinkers, and
5.6% of participants consumed alcohol a few times per
week to daily (daily consumption of alcohol reported 90
(1.2%) individuals). The proportion of men who reported
consumption of a particular alcoholic beverage was
16.8% for wine, 89.5% for vodka, and 32.5% for beer.
Higher quantity per one occasion reported 16.1% of beer
consumers, 16.9% of wine consumers and 74.0% of
vodka consumers. There were 185 gastric cancer cases
during the follow-up period corresponding to 137,187
person years.
Effect of drinking frequency and ethanol amount
Compared to men who drank a few times per year, men
in the highest category of alcohol drinking frequency
(2–7 times per week) had a statistically significant
increased risk of gastric cancer (Table 2). The hazard
ratio for developing cancer among men who consumed
≥100.0 g/week of ethanol was a statistically significantly
increased compared to men who drank 0.1–9.9 g/week,
furthermore, the multivariate adjusted HR per 1 SD (90
g/week) increase in ethanol intake was statistically sig-
nificant (Table 2). The relationship was strengthened
after further adjustment for acetaldehyde intake: for
heavy (≥100.0 g/week) ethanol intake HR was 2.82 (95%
CI: 1.08–7.41), although, addition of acetaldehyde intake
variable to a model did not markedly increase the pre-
dictive capacity of the model, p = 0.13 (data not shown).
In this cohort, during the 30-year follow-up period, 8.4%
of the cancer cases would not have occurred if heavy al-
cohol consumption (≥100.0 g/week) had not occurred.
A total of 110 gastric cancer cases were identified dur-
ing the second half of the follow-up period from January
1993 through December 2008 among the 5,425 men
who were alive on 1 January 1993. Similar to the results
Table 1 Selected characteristics of cohort members by alcohol consumption frequency
Characteristic Alcohol consumption frequency
Non-drinkers A few times per year 1–4 times per month 2–7 times per week
Cases, n (%) 11 (5.9%) 27 (14.6%) 132 (71.4%) 15 (8.1%)
Participants, n (%) 582 (8.1%) 1239 (17.3%) 4930 (69.0%) 399 (5.6%)
Person-years 10,761 24,947 94,719 6,759
Age at baseline (years)a 53.5±5.6 53.1±5.7 52.3±5.8 53.1±5.7
Age at diagnosis (years)a 67.6±5.9 65.8±9.2 66.7±8.4 68.5±6.1
BMI (kg/m2)a 27.4±3.7 27.2±3.6 27.4±3.8 26.8±4.0
Current smoking (%)
Never 40.9 45.1 25.7 16.5
Former 33.8 26.6 22.5 18.5
Smoker:
≤10 cig/day 9.6 11.7 14.8 12.0
11–19 cig/day 4.3 4.5 9.9 8.8
≥20 cig/day 10.5 10.8 24.9 42.6
Unknown 0.9 1.2 2.2 1.5
Alcohol intake, g/weeka 0 2.5±1.1 56.7±22.1 432.5±195.1
Married (%) 93.5 95.8 95.1 93.5
Education (%)
Primary 24.0 15.5 23.5 34.3
Unfinished secondary 27.7 26.3 28.5 29.1
Secondary 26.5 26.7 25.8 26.3
Higher 20.8 30.2 21.1 8.0
Unknown 1.0 1.3 1.1 2.3
aData are presented as mean ± SD.
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significantly associated with an increased risk of gastric
cancer; furthermore, the association became stronger
(Table 2).
In the multivariate analysis, smoking was associated
with a non-significantly increased risk of gastric cancer,
HR = 1.48 (95% CI: 0.88–2.49) for men who smoked
10–19 cigarettes per day and 1.39 (95% CI: 0.92–2.10)
for men who smoked ≥20 cigarettes per day (compared
to never smokers).
Type of alcoholic beverage
Higher consumption of beer or vodka per one occasion
was not statistically significantly associated with a risk of
gastric cancer in this cohort of men (Table 3). The gas-
tric cancer incidence rate for heavy wine drinkers was
very high in comparison with heavy beer drinkers or
heavy vodka drinkers (Table 3). In a multivariate
adjusted model, heavy wine consumption was positively
related to a risk of gastric cancer, HR = 2.95 (95% CI:
1.30–6.68) for men who consumed ≥0.5 litre per occa-
sion compared with those who consumed less (based on
10 cases, mutually adjusted for beer and vodka) (Table 3).In an analysis by ethanol intake from each type of alco-
holic beverage, after adjustment for smoking, education
level, BMI and the other two beverage types, HRs for
the highest category of beer, wine and vodka consump-
tion were not significantly elevated, HR = 1.52 (95% CI:
0.66–3.51), based on 16 cases, 1.72 (95% CI: 0.67–4.40),
based on 17 cases, and 1.50 (95% CI: 0.66–3.42), based
on 13 cases, respectively (Figure 2). Tests for trend were
statistically not significant.
Acetaldehyde intake
Figure 3 shows the association between total acetalde-
hyde intake and the gastric cancer in the multivariate
analyses. HR adjusted for smoking, education level and
body mass index among men within the 5th quintile was
significantly increased compared to those within the 1st
quintile (HR = 1.66 (95% CI: 1.04–2.65). The HR per 1
SD (11.8 mg of acetaldehyde per week) was 1.08 (95%
CI: 0.98–1.19). The association for intake of acetalde-
hyde did not persist after inclusion of ethanol intake in
the model (HR = 0.60 (95% CI: 0.24–1.52), trend analysis
showed no dose–response relationship; p value for the
addition of the ethanol intake variable was <0.05.
Table 2 Hazard ratios of gastric cancer incidence according to alcohol consumption
Alcohol category No. of cases Person-years Incidence rate/10,000
person-years
HR (95% CI)a HR (95% CI)b
Follow-up from 1978 through 2008
Frequency
Non-drinkers 11 10,761 10.2 0.95 (0.47–1.92) 0.96 (0.47– 1.93)
A few times per year 27 24,948 10.8 1 (reference) 1 (reference)
1–4 times per month 132 94,719 13.9 1.37 (0.90–2.08) 1.27 (0.83–1.94)
2–7 times per week 15 6,759 22.2 2.19 (1.16–4.13) 2.00 (1.04–3.82)
p-trendc 0.11
Ethanol intake
Non-drinkers 11 10,761 10.2 0.94 (0.47–1.89) 0.95 (0.47–1.90)
0.1–9.9 g/week 29 26,574 10.9 1 (reference) 1 (reference)
10.0–24.9 g/week 56 48,660 11.5 1.10 (0.70–1.72) 1.04 (0.66–1.64)
25.0–99.9 g/week 56 34,858 16.1 1.57 (1.00–2.46) 1.44 (0.91–2.29)
≥100.0 g/week 33 16,334 20.2 2.07 (1.26–3.42) 1.90 (1.13–3.18)
Continuous, per 1 SD (90 g/week)c 1.12 (1.00–1.25)
Follow-up from 1993 through 2008
Frequency
Non-drinkers 7 9,676 7.2 1.32 (0.52–3.30) 1.34 (0.53–3.36)
A few times per year 13 23,282 5.6 1 (reference) 1 (reference)
1–4 times per month 79 86,369 9.2 1.88 (1.04–3.39) 1.81 (1.00–3.29)
2–7 times per week 11 5,917 18.6 3.95 (1.76–8.84) 3.99 (1.75–9.11)
p-trendc 0.007
Ethanol intake
Non-drinkers 7 9,676 7.2 1.20 (0.49–2.95) 1.23 (0.50–3.01)
0.1–9.9 g/week 15 24,707 6.1 1 (reference) 1 (reference)
10.0–24.9 g/week 32 44,576 7.2 1.32 (0.71–2.44) 1.29 (0.69–2.39)
25.0–99.9 g/week 36 31,626 11.4 2.13 (1.16–3.88) 2.06 (1.11–3.81)
≥100.0 g/week 20 14,658 13.6 2.74 (1.40–5.36) 2.74 (1.37–5.49)
Continuous, per 1 SD (90 g/week)c 1.17 (1.03–1.32)
aStratified by study. Age was used as the underlying time metric for all analyses.
bStratified by study and adjusted for smoking (never, former, ≤10 cig/day, 11–19 cig/day, ≥20 cig/day); education (primary, unfinished secondary, secondary,
higher); BMI. Age was used as the underlying time metric for all analyses.
cTest for trend was carried out after exclusion of non-drinkers.
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In this population-based cohort study with a long
follow-up period, a significant association between alco-
hol consumption and increased risk of gastric cancer
was observed. Men within the group of the highest alco-
hol consumption frequency had a twofold increased risk
of gastric cancer compared with occasional drinkers. A
statistically significant positive association between the
amount of ethanol intake and gastric cancer was also
observed. Our results suggest that the fraction of cancer
cases attributable to alcohol consumption in this cohort
is approximately 8%.
Previous studies have reported inconsistent results
[5,6,8-20,30-32]. A positive association with heavyalcohol drinking was observed in a prospective study of
men from China (HR = 1.46 (95% CI: 1.05–2.04)) and in
men from a European Prospective Investigation into
Cancer and Nutrition (EPIC) study (HR = 1.65 (95% CI:
1.06–2.58)) [18,19]. Furthermore, a meta-analysis of 44
case–control and 15 cohort studies showed a relation-
ship with heavy drinking, HR = 1.20 (95% CI: 1.01–1.44)
[20]. Our results showed that higher alcohol consump-
tion increases gastric cancer risk. This observation is in
agreement with those studies that found an association
between alcohol drinking and the risk of gastric cancer
[14,16-20].
A stronger effect of alcohol consumption on gastric
cancer risk was observed in our study during the period
Table 3 Hazard ratios of gastric cancer by type of alcoholic beverage and intake per one occasion






HR (95% CI)a HR (95% CI)b
Beer
0 121 93,036 13.0 0.84 (0.59–1.20) 0.83 (0.58–1.18)
<1 litre 54 37,541 14.4 1 1 (reference)
≥1 litre 10 6,611 15.1 0.82 (0.40–1.67) 0.79 (0.39–1.62)
p-trendc 0.60
Wine
0 156 115,296 13.5 1.50 (0.89–2.53) 1.47 (0.87–2.50)
<0.5 litre 19 18,636 10.2 1 1 (reference)
≥0.5 litre 10 3,254 30.7 3.18 (1.41–7.14) 2.95 (1.30–6.68)
p-trendc 0.65
Vodka, MIHDPSd
0 14 11,298 12.4 1.22 (0.65–2.30) 1.20 (0.63–2.25)
<200 g 31 29,633 10.5 1 1 (reference)
≥200 g 97 67,291 14.4 1.42 (0.94–2.13) 1.25 (0.82–1.92)
p-trendc 0.55
Vodka, KRIS
0 1 2,466 4.0 0.37 (0.04–3.29) 0.37 (0.04–3.36)
<100 g 4 3,929 10.2 1 1 (reference)
≥100 g 38 22,570 16.8 1.69 (0.60–4.79) 1.51 (0.52–4.36)
p-trendc 0.11
aStratified by study. Mutually adjusted for the other two beverage types.
bStratified by study and adjusted for smoking (never, former, ≤10 cig/day, 11–19 cig/day, ≥20 cig/day); education (primary, unfinished secondary, secondary,
higher); BMI. Mutually adjusted for the other two beverage types. Age was used as the underlying time metric for all analyses.
cTest for trend was carried out across three categories by fitting ordinal variable ‘amount per one occasion’ as continuous.
dResults for MIHDPS and KRIS participants are presented separately due to differences in questionnaire design.
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increasing alcohol intake over time among study partici-
pants could influence these results. According to a
WHO MONICA study carried out in Kaunas among
men 35–64 years of age, the frequency of alcohol con-
sumption and average amount drunk increased markedly
in 2001–2002 compared to 1983–1984, despite some re-
duction noticed in 1986–1993 [33]. Another possible ex-
planation for this is that a longer latency period was
associated with a stronger relationship between alcohol
consumption and risk of gastric cancer.
Our study observed an increased risk among greater
consumers of wine. Men who consumed ≥0.5 litre of
wine per occasion had an increased risk of gastric cancer
compared with those who consumed less. In addition, a
very high incidence rate was observed among heavy wine
consumers but not among heavy drinkers of the other
beverage types, supporting the association between the
heavy consumption of wine and gastric cancer. When
we estimated wine consumption using a measure that
combines quantity and frequency (i.e. grams of ethanol
per week), we observed increased risk, but not statisti-
cally significant. Thus, our data suggest the greaterimportance of quantity of wine consumption. However,
we cannot rule out the possibility that the significant risk
increase among greater consumers of wine was a chance
finding due to relatively small number of cases in wine
drinkers. In analyses of the effect of estimated ethanol
intake by beverage type, we found no significant associ-
ation with beer or vodka consumption. There are mixed
findings about the relation between the type of alcoholic
beverage and the incidence of gastric cancer. Wine
drinking was significantly associated with a risk of devel-
oping gastric cancer in a study in Mexico, for the highest
category of wine intake Odds ratio (OR) = 2.93 (CI 95%:
1.27–6.75) [34]. In Portugal, consumption of more than
one bottle of red wine per day 20 years prior to the
interview was also associated with a gastric cancer risk,
OR = 2.61 (p = 0.049) [35]. In Lithuania, a case–control
study demonstrated a positive association between wine
consumption and gastric cancer risk, but no association
with beer or spirits [36]. In contrast, several studies
showed that wine may be comparatively less carcino-
genic, and a daily intake of wine may prevent the devel-
opment of gastric cancer [11,37]. No association with








































































Figure 2 Hazard ratios (95% CI) of gastric cancer by ethanol intake for each alcoholic beverage type: beer (A), wine (B) and vodka (C).
Models stratified by study; adjusted for smoking, education, BMI. Mutually adjusted for the other two beverage types.
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http://www.biomedcentral.com/1471-2407/12/475recent EPIC cohort, but there was a positive association
for beer, HR = 1.75 (95% CI: 1.13– 2.73) for ≥30 g/day
[19]. A strong effect of alcohol, particularly vodka con-
sumption, was observed in case–control studies of
gastric cancer in Russia and Uruguay [16,17]. No as-
sociation with alcohol intake was found in a study
from Poland, although it was suggested that heavy
drinkers with a slow elimination of acetaldehyde due to
polymorphism in alcohol metabolizing gene (ALDH2)
had an excess risk [6,38].
Several mechanisms have been proposed to explain
the possible role of alcohol in gastric cancer develop-
ment. The ethanol in alcoholic beverages is considered
to be “the principal ingredient that renders these bev-
erages carcinogenic” [4,21]. Ethanol induces various re-
active oxygen species and oxidative stress, which
damage the DNA and affect its repair. Chronic ethanol
intake is known to induce cytochrome P450 2E1
(CYP2E1) in various organs, including gastrointestinal
tract, which affect conversion of pro-carcinogens
(present in alcoholic beverages, tobacco smoke and
diet) into carcinogens [4,39,40]. Ethanol may further
act as a solvent for these carcinogens to enter the cell
in the mucosa of the stomach, it may also have direct
physical effect on the tissue [39]. In the body, ethanol
is converted by alcohol dehydrogenase and CYP2E1 to
acetaldehyde. Acetaldehyde may promote carcinogen-
esis by causing point mutations, inducing sister-
chromatid exchanges, impairing DNA repair, inducingmetaplasia of epithelium, and forming mutagenic
adducts with DNA [40]. It has been shown, that acetal-
dehyde outside ethanol metabolism poses a risk for
drinkers of alcoholic beverages above the risk of etha-
nol and metabolically formed acetaldehyde [21]. In
addition, beer consumption results in exposure to vola-
tile N-nitroso compound N-nitrosodimethylamine
(NDMA), which is a potent carcinogen in animals [41].
One hypothesis that might explain the high risk of
gastric cancer associated with alcohol in Lithuania is
the presence of contaminants, e.g. acetaldehyde, which
has been classified as carcinogenic to humans (Group 1)
[4,21,42]. There is no data on the NDMA levels in beer
on the market in Lithuania; however, high levels of
acetaldehyde have been detected in fruit-based liquor
samples from Central European countries [43]. Epi-
demiological evidence on acetaldehyde as an independ-
ent risk factor for cancer during alcohol consumption,
in addition to the effects of ethanol, is limited. We
addressed the possibility that acetaldehyde consumption
may confer some increased risk of gastric cancer or may
be a confounding factor. This has, to our knowledge, not
been previously examined. We repeated analyses of etha-
nol intake adjusting for total acetaldehyde intake. Fur-
thermore, we performed analysis of acetaldehyde with
and without adjustment for ethanol intake. In those ana-
lyses results suggested increased risk with ethanol intake
and no association with acetaldehyde intake after mutual























education and BMI  
Adjusted for smoking,
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Figure 3 Hazard ratios of gastric cancer by acetaldehyde intake among alcohol consumers. Models stratified by study; adjusted for
smoking, education, BMI, before and after adjustment for ethanol intake.
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ered in the present analysis as confounding factors. Wine
has the highest acetaldehyde content, but it also contains
substances thought to be protective. Therefore, it is likely
that when both acetaldehyde and ethanol were included in
the same statistical model as covariates, reduced HRs for
acetaldehyde were obtained due to this confounding. In
contrast, the analysis by beverage type revealed increased
gastric cancer risk among higher consumers (≥0.5 litre per
one occasion) of wine suggesting that the relation could
be attributed to the higher content of acetaldehyde in
wine. Thus, interpretation is difficult given positive correl-
ation between ethanol and acetaldehyde intake and lim-
ited statistical power because the majority of the cohort
participants reported no or low consumption of wine or
beer. Since wine and beer have higher acetaldehyde con-
centrations than do white spirits (vodka) [21], and since
many countries have higher consumption of wine and
beer, this does not rule out an acetaldehyde effect among
more heavily exposed alcohol consumers.Here we only studied men and it may be, that these
results are not directly applicable to women. Previous
studies reported conflicting results on alcohol con-
sumption and gastric cancer risk by gender: two stud-
ies revealed higher risk associated with alcohol
consumption among men than among women [11,16],
in one an association was significant only in men but
not in women [19], whereas one found no significant
differences in risk among men and women [20].
The major strengths of this study include its prospect-
ive and population-based design, long follow-up time,
and the completeness of follow-up through the use of
population-based registers. In addition, we controlled for
a range of potential confounding variables, including
smoking, body mass index, education, age and acetalde-
hyde intake. The study also has limitations. The first limi-
tation is the lack of data on diet, alcohol use in the past,
Helicobacter pylori infection status, and histological sub-
type or cancer anatomical subsite. Fresh fruit and vege-
table intake is inversely, whereas red and processed meat
Everatt et al. BMC Cancer 2012, 12:475 Page 10 of 11
http://www.biomedcentral.com/1471-2407/12/475and salt intake is positively, associated with the risk of gas-
tric cancer [2]. An increased risk associated with heavier
drinking might be due to poor nutrition, as heavy drinkers
are known to have less healthy dietary habits [44]. We
cannot rule out the possibility that the observed associa-
tions between alcohol consumption and gastric cancer risk
were confounded by factors that we have not accounted
for. However, in several other studies, the adjustment for
potentially confounding variables, including dietary factors
or H. pylori serology, did not materially change the associ-
ation between alcohol consumption and risk of gastric
cancer [12,18,20]. The second limitation is the assessment
of alcohol intake at a single point in time. There is a po-
tential for misclassification of exposure due to possible
changes in alcohol intake over time. If alcohol consump-
tion increased with time, this could lead to an overesti-
mation of the risk among moderate drinkers. The third
limitation is the assessment of alcohol intake based on a
questionnaire, therefore underreporting or misclassifica-
tion might have occurred. Our ability to assess relation-
ships was limited by the lack of detailed questionnaire on
alcohol consumption. Furthermore, we had no informa-
tion on specific type of spirits, thus we were unable to take
into account an acetaldehyde intake from fruit-based spir-
its. However, findings indicate that the traditional vodka
drinking culture prevaled at the time of baseline surveys
[45]. Because of the prospective design of the present
study, any misclassification of alcohol intake would be
non-differential and would tend to dilute the true associ-
ation. The further limitation is that the results of analyses
were based on a small number of gastric cancer cases.
Thus, it cannot be excluded that the associations were
observed by chance.Conclusions
The results from the present cohort study support an as-
sociation between higher consumption frequency or
higher alcohol intake and the risk of gastric cancer
among men. This prospective study suggests that the ef-
fect was due to total ethanol intake. Although an excess
risk among men within the highest wine consumption
group was observed, an association between exposure to
acetaldehyde and risk of gastric cancer in this cohort
was not confirmed. Our findings imply that public
health recommendations to reduce the gastric cancer
burden need to include a reduction in alcohol consump-
tion. However, further research is needed to provide a
more detailed evaluation of alcohol drinking, possible
important confounding factors and anatomical subsites
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